Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
atrial flutter/potassium
Le lien est enregistré dans le presse-papiers
10 résultats
Compounds and their use as IKACh blockers
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
TECHNICAL FIELD
The present invention relates to a novel class of compounds which are pharmacologically effective as potassium channel inhibitors, in particular inhibitors of the acetylcholine operated inward rectifying potassium channel current, i.e. IKACh blockers.
The invention also relates to
Indanyl-substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicament, and pharmaceutical preparations comprising them
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This application is a national stage application under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2011/065,713, filed Sep. 12, 2011, the disclosure of which is explicitly incorporated by reference herein.
The invention relates to 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine
Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This application is a national stage application under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2011/066061, filed Sep. 16, 2011, the disclosure of which is explicitly incorporated by reference herein.
The invention relates to 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine compounds
Fused pyrroledicarboxamides and their use as pharmaceuticals
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The present invention relates to fused pyrroledicarboxamides of the formula I,
##STR00002## in which R1 to R9, X, m and n are as defined below. The compounds of the formula I are inhibitors of the acid-sensitive potassium channel TASK-1 and suitable for the treatment of TASK-1 channel-mediated
Fused pyrroledicarboxamides and their use as pharmaceuticals
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This application is a national stage application under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2013/051996, filed Feb. 1, 2013, the disclosure of which is explicitly incorporated by reference herein.
The present invention relates to fused pyrroledicarboxamides of the formula
Indanyl-substituted benzenecarboxamides, processes for their preparation, their use as a medicament, and pharmaceutical formulations containing them
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The invention relates to compounds of formula I ##STR2##
in which R(8) is either a 1-indanyl radical of formula II or a 2-indanyl radical of formula III ##STR3##
and in which R(1), R(2), R(3), R(4), R(5), R(6), R(7), R(9), R(10), R(11), R(12), R(13), R(14), and R(15) have the meanings stated below,
Anthranilamides with heteroarylsulfonyl side chain, process of preparation, and use
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
DESCRIPTION
The invention relates to compounds of formula I, represented in the structure below, in which R1, R2, R3, R4, R5, R6 and R7 have the meanings as stated below, and to the use thereof, especially in pharmaceuticals.
##STR00002## The present invention encompasses compounds of formula I
Anthranilamides and methods of their use
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The invention relates to compounds of formula I, ##STR00002## in which R(1), R(2), R(3), R(4), R(5), R(6) and R(7) have the meanings indicated hereinafter, to their preparation and use, and in particular, to their use as pharmaceuticals.
The compounds of formula I have not previously been disclosed.
Anthranilamides with heteroarylsulfonyl side chain, process of preparation, and use
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This application claims the priority of German application No. 10128331.8, filed on Jun. 12, 2001, under 35 U.S.C. 119, which is incorporated by reference.
DESCRIPTION
The invention relates to compounds of formula I, represented in the structure below, in which R1, R2, R3, R4, R5, R6 and R7 have the
Anthranilamides and methods of their use
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This application is a CON of 10/132,163, filed Apr. 26, 2002.
The invention relates to compounds of formula I,
##STR00002## in which R(1), R(2), R(3), R(4), R(5), R(6) and R(7) have the meanings indicated hereinafter, to their preparation and use, and in particular, to their use as
La base de données d'herbes médicinales la plus complète soutenue par la science
- Fonctionne en 55 langues
- Cures à base de plantes soutenues par la science
- Reconnaissance des herbes par image
- Carte GPS interactive - étiquetez les herbes sur place (à venir)
- Lisez les publications scientifiques liées à votre recherche
- Rechercher les herbes médicinales par leurs effets
- Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets
Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées
